[HTML][HTML] Intravenous levothyroxine for unstable brain-dead heart donors
R Dhar, GF Marklin, WD Klinkenberg… - … England Journal of …, 2023 - Mass Medical Soc
Background Hemodynamic instability and myocardial dysfunction are major factors
preventing the transplantation of hearts from organ donors after brain death. Intravenous …
preventing the transplantation of hearts from organ donors after brain death. Intravenous …
The role of thyroid hormone administration in potential organ donors
A Salim, P Vassiliu, GC Velmahos, J Sava… - Archives of …, 2001 - jamanetwork.com
Hypothesis Levothyroxine sodium therapy should be used in brain-dead potential organ
donors to reverse hemodynamic instability and to prevent cardiovascular collapse, leading …
donors to reverse hemodynamic instability and to prevent cardiovascular collapse, leading …
Aggressive pharmacologic donor management results in more transplanted organs1
JD Rosendale, HM Kauffman, MA McBride… - …, 2003 - journals.lww.com
Background. Brain death results in adverse pathophysiologic effects in many cadaveric
donors, resulting in cardiovascular instability and poor organ perfusion. Hormonal …
donors, resulting in cardiovascular instability and poor organ perfusion. Hormonal …
Hormonal resuscitation yields more transplanted hearts, with improved early function1
JD Rosendale, HM Kauffman, MA McBride… - …, 2003 - journals.lww.com
Background. Brain death results in cardiovascular instability and poor organ perfusion in
many brain-dead donors. Hormonal resuscitation stabilizes certain brain-dead donors and is …
many brain-dead donors. Hormonal resuscitation stabilizes certain brain-dead donors and is …
Using thyroid hormone in brain‐dead donors to maximize the number of organs available for transplantation
The aggressive management of brain‐dead (cadaveric) organ donors has been shown to
increase organs available for transplantation. Some centers use hormone therapy with …
increase organs available for transplantation. Some centers use hormone therapy with …
A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors
PS Macdonald, A Aneman, D Bhonagiri… - Critical care …, 2012 - journals.lww.com
Objectives: To review all published clinical studies of thyroid hormone administration to
brain-dead potential organ donors. Methods: A search of PubMed using multiple search …
brain-dead potential organ donors. Methods: A search of PubMed using multiple search …
Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: a retrospective analysis
D Novitzky, Z Mi, Q Sun, JF Collins… - Transplantation, 2014 - journals.lww.com
Background Hormonal therapy to the brain-dead potential organ donor can include thyroid
hormone (triiodothyronine [T 3] or levothyroxine [T 4]), corticosteroids, antidiuretic hormone …
hormone (triiodothyronine [T 3] or levothyroxine [T 4]), corticosteroids, antidiuretic hormone …
Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy.
V Jeevanandam, B Todd, T Regillo… - The Journal of Heart …, 1994 - europepmc.org
Triiodothyronine deficiency after brain death can result in progressive deterioration of
cardiac function in potential organ donors. We report on the use of triiodothyronine …
cardiac function in potential organ donors. We report on the use of triiodothyronine …
[HTML][HTML] Eficiency of triiodothyronine treatment on organ donor hemodynamic management and adenine nucleotide concentration
A Pérez-Blanco, J Caturla-Such… - Intensive care …, 2005 - Springer
Objective We compared hemodynamic values, oxygen utilization, and adenine nucleotide
concentration in the extracted organs of brain-dead donors treated with triiodothyronine vs …
concentration in the extracted organs of brain-dead donors treated with triiodothyronine vs …
Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient
D Novitzky, DKC Cooper, JS Chaffin, AE Greer… - …, 1990 - journals.lww.com
Brain death is associated with neuroendocrine changes, in particular with a significant
reduction of plasma-free triiodothyronine (T3) that results in impaired aerobic metabolism …
reduction of plasma-free triiodothyronine (T3) that results in impaired aerobic metabolism …